![]() | Only 14 pages are availabe for public view |
Abstract Stress urinary incontinence (SUI) is a common social problem that affect about 4-35% of adult women and defined by the International Continence Society (ICS) as the involuntary leakage of urine on exertion, sneezing or coughing [1, 2]. There are two main theories that clarified the pathophysiology of stress urinary incontinence, urethral hypermobility due to weakness in the urethral support and intrinsic sphincteric deficiency. Both mechanisms usually coexist together and affect the development and selection of surgical techniques [3]. There are multiple options for treatment of stress urinary incontinence including urethral bulking agents, retropubic urethral suspension procedures (eg Marshall-Marchetti-Krantz or Burch), transvaginal suspension, autologous pubovaginal sling and synthetic midurethral sling (Transobturator tape and tension-free vaginal tape). Slings are the most effective and durable form of treatment [4]. Slings are generally composed of synthetic mesh or autologous slings. The latter are harvested from the rectus fascia, fascia lata, or vaginal mucosa[5]. In the last twenty years, the synthetic midurethral sling (MUS) has been considered the gold standard surgical treatment for index SUI patients after failure of conservative treatments as it is an effective minimally invasive procedure with little operative morbidity [6]. |